SnesTech WKN: A40HK3 ISIN: US81720R6045 Forum: Aktien User: Standard

https://www.prnewswire.com/news-releases/senestech-reports-significant-reductions-in-rodent-activity-following-evolve-deployments-in-urban-field-studies-302691116.html

Glenbrook accumulated some shares https://finviz.com/quote.ashx?t=SNES&ty=c&ta=1&p=d + There are a few positive technical indicators — a double bottom and a potential trend reversal on the weekly chart — and I suspect that most investors are deeply in the red and that some want to lower their average purchase price.

Glenbrook Capital Management, a 10% owner, has reported the acquisition of common shares of SenesTech Inc. The full filing can be accessed through the link below

Palette ~ 10k$ Container 5-10 Paletten https://www.youtube.com/live/lP0dEJEIf6U?si=7atrfBf9hz-3Q_GH Deployment Plan ongoing

https://www.prnewswire.com/news-releases/senestechs-evolve-approved-in-new-zealand-302675862.html PHOENIX, 2. Februar 2026 /PRNewswire/ -- SenesTech, Inc. (Nasdaq: SNES), ein Pionier in der Fruchtbarkeitskontrolllösungen für die Bewirtschaftung von Nagetierpopulationen, freut sich bekannt zu geben, dass Evolve® vom Ministerium für Primärindustrie für den Einsatz in Neuseeland zugelassen wurde. Der exklusive Vertriebspartner von SenesTech, Evicom, hat seinen ersten Lagerauftrag erhalten. Die Überbevölkerung von Nagetieren bleibt eine große ökologische und wirtschaftliche Herausforderung in Neuseeland und bedroht die einheimische Tierwelt, die Landwirtschaft und die städtische Umwelt. Evolve ist eine revolutionäre Lösung zur Geburtenkontrolle, die die Fortpflanzung von Nagetieren an ihrer Quelle einschränkt und eine nicht tödliche, umweltbewusste Alternative bietet, die sich nahtlos in bestehende IPM-Strategien einfügt. Die neuseeländische Initiative Predator Free 2050 ist eines der ehrgeizigsten Naturschutzprogramme der Welt, das darauf abzielt, invasive Raubtiere wie Ratten, Staat und Opossums zu beseitigen, um einheimische Arten zu schützen. Neuseeland erwartet, über 4,5 Milliarden US-Dollar für dieses Programm auszugeben, wobei es sich ausdrücklich auf technologische Fortschritte und die Entwicklung effizienterer und effektiverer Ausrottungsmethoden zur Erreichung ihrer Ziele verlässt. Evolve stellt einen idealen Partner für diese Bemühungen dar, da es Rattenpopulationen ohne den Kollateralschaden von Giften reduziert und die Artenvielfalt und empfindliche Ökosysteme im Einklang mit den Erhaltungszielen Neuseelands bewahrt. "Wir erfüllen unsere Strategie, weltweit führend bei nachhaltigen Fruchtbarkeitskontrolllösungen für die Bewirtschaftung von Rattenpopulationen zu werden und nutzen gleichzeitig bedeutende, wachstumsstarke Märkte, die aktiv nach nachhaltigen und wirksamen Alternativen zu traditionellen Rodentiziden suchen", sagte Joel Fruendt, Präsident und CEO von SenesTech. "Die Evolve-Produkte stehen im Einklang mit sich ändernden regulatorischen Standards und Umweltrichtlinien. Dies ist besonders für Neuseeland von entscheidender Bedeutung, wo der Schutz einheimischer Wildtiere eine nationale Priorität hat." "Wir haben einen Container verschickt, um das Produkt in Neuseeland auf den Markt zu bringen, und erwarten, dass wir einen regelmäßigen Versandplan mit Evicom einhalten werden", fuhr Fruendt fort.

SenesTech, Inc. (NASDAQ:SNES), a pioneer in fertility control solutions for managing rodent populations, is pleased to announce that Evolve® has been approved for use in New Zealand by the Ministry for Primary Industries. SenesTech's exclusive distribution partner, Evicom, has been shipped its initial stocking order.

Q3 2025 Financial Highlights • Revenues increased by 43% to $690,000, a record for the Company, from $482,000 in Q3 2024. • Evolve® Rodent Birth Control product sales grew 77% year-over-year, now representing 85% of total revenue. • Gross profit margin was 62.8%, in line with expectations. • Net loss for Q3 2025 was $1.3 million, compared to $1.5 million in Q3 2024. Q3 2025 included $111,000 in one-time legal expenses and $49,000 in non-cash operating lease expense. Excluding these non-operational costs, the Company’s net loss would have been $1.1 million for Q3 2025. • Adjusted EBITDA loss improved to $1.2 million in Q3 2025, a record for the Company, compared to $1.4 million in the same quarter of the prior year. • Cash and short-term investments of $10.2 million provide the Company with a solid operating runway for the foreseeable future. Q3 2025 Operational and Strategic Highlights • Product Expansion: The higher-margin Evolve Rat and Evolve Mouse products, launched in 2024, grew 77% year- over-year and are the largest revenue drivers for SenesTech, representing 85% of total revenue. These products are designed for proactive rodent fertility control and continue to gain traction among pest management professionals and consumers. • E-commerce Growth: E-commerce revenue increased 55% year-over-year, driven by double digit growth in Amazon sales. We are also seeing accelerating growth across other e-commerce sites including Walmart.com, and HomeDepot.com. • Municipal Deployment: Municipal revenue grew 139% year-over-year due to expanded deployments in New York City, Chicago, and other locations, reflecting increased adoption in diverse urban settings. Current programs continue to focus on controlled deployments in high-impact areas, laying the groundwork for potential large-scale expansion. Municipal deployments also have a positive impact on other channels such as retail, e-commerce and pest control distribution. • Retail Market Adoption: Retail revenue grew 254% year-over-year, driven by expanded adoption by Ace Hardware, which more than doubled its coverage area during the quarter, and follow-on orders from Bradley Caldwell, a wholesaler serving over 8,000 retail locations in the Northeast. Future growth is also expected from retailers who begin with e-commerce before expanding to in-store offerings. • Pest Management: Pest management professionals (PMPs) continue to utilize Evolve in their service offerings, boosting revenue by 29% year-over-year and up 72% sequentially. PMPs represented nearly 20% of the Company’s overall Q3 2025 revenue, leveraging the unique attributes of fertility control across a wide range of customer applications, including theme parks.

Vor 2 Wochen https://youtu.be/5sT6RDlG584?si=D3Ow9CTa7mcNwGw2

SenesTech Inc. has appointed Michael Edell as Interim Chief Operating Officer, effective October 15, 2025. Edell brings extensive experience from his leadership roles at Westlake Serial Company, Rancher's Pride, MaddieBrit Products, and Waterleaf Paper Company. He has no family ties to current executive officers or directors of SenesTech.

https://finviz.com/news/190576/swampscott-launches-pilot-of-senestechs-innovative-rat-birth-control-at-firehouse-and-local-school

https://www.prnewswire.com/news-releases/senestechs-evolve-rat-birth-control-now-available-online-at-homedepotcom-302551628.html

Ja passt auf Amazon UK gibt’s die Sachen noch nur für D nicht.

Etwas seltsam kann Homedepot nicht öffnen und Amazone gibt’s evolve auch nicht mehr. Evtl. Liegt am D Standort

$SNES - SenesTech's Evolve Rat Birth Control Now Available Online at

SenesTech, Inc. has announced a new order for its rodent control solution, Evolve™ Rat Birth Control, to be deployed in Chicago's Old Town Special Service Area #48. This initiative, spearheaded by the Old Town Merchants and Residents Association, aims to enhance sanitation and public health in the neighborhood. The deployment will target strategic alleyways across key commercial and residential areas. Evolve is a non-toxic, EPA-classified, minimum-risk pesticide designed to reduce rodent fertility, making it ideal for urban areas. This program builds on successful rodent management strategies in other cities like New York, Boston, and Baltimore. The initiative aligns with SSA #48's mission to foster a cleaner and more sustainable neighborhood environment.

https://www.usatoday.com/story/news/nation/2025/08/17/rats-raiding-california-almond-orchards/85658990007/